Immatics NV Appoints Venkat Ramanan as New Chief Financial Officer, Succeeding Arnd Christ
Immatics NV has appointed Venkat Ramanan, Ph.D., as its new Chief Financial Officer, effective immediately. Dr. Ramanan has over 25 years of experience in the biopharmaceutical industry, previously serving as CFO at Anthos Therapeutics and holding senior roles at Seagen, Gilead Sciences, and Amgen. He succeeds Arnd Christ in the CFO position.
Immatics NV has announced the appointment of Venkat Ramanan, Ph.D., as its new Chief Financial Officer, effective immediately. Dr. Ramanan brings over 25 years of experience in the biopharmaceutical industry, having previously served as CFO at Anthos Therapeutics and held senior roles at Seagen, Gilead Sciences, and Amgen. He succeeds Arnd Christ in the CFO role. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immatics NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001130803-en) on October 01, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
